UNIVASC Side Effects

5618238-4 | Platelet Count Decreased
on Feb 06, 2008 Male patient from UNITED STATES , weighting 180.0 lb, was diagnosed with hypertension and was treated with Univasc (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Univasc dosage: One Tablet Daily Po.

5368677-4 | Pruritus, Rash
Patient was taking Univasc (View Usage). Patient had the following side effects: pruritus, rash (What is rash?) on Jul 24, 2006 from UNITED STATES Additional patient health information: Female patient , 59 years of age, weighting 170.0 lb, was diagnosed with hypertension and. Univasc dosage: 7.5 Mg, 1once, Oral. During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), ESTRADIOL (View Estradiol Review and Estradiol Label ).

5368653-1 | Blood Pressure Systolic Decreased, Tachycardia
Adverse event was reported on Nov 10, 2006 by a Female patient taking Univasc (View Usage) (Dosage: Oral) . Location: UNITED STATES , 78 years of age, After Univasc was administered, patient had the following side effects: blood pressure systolic decreased, tachycardia.

5368652-X | Blood Pressure Inadequately Controlled, Hormone Level Abnormal, Hypertension, Inflammation, Renal Disorder
on Jun 22, 2006 Male patient from UNITED STATES , 64 years of age, weighting 179.0 lb, was diagnosed with hypertension and was treated with Univasc (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure inadequately controlled, hormone level abnormal, hypertension, inflammation, renal disorder. Univasc dosage: 15mg, 1 In 1 D, Oral. During the same period patient was treated with GLYBURIDE (View Glyburide Review and Glyburide Label ), ROSIGLITAZONE MALEATE (View Rosiglitazone Maleate Review and Rosiglitazone Maleate Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).


5368548-3 | Blood Pressure Inadequately Controlled
on May 09, 2006 Female patient from UNITED STATES , 46 years of age, weighting 140.0 lb, was diagnosed with hypertension and was treated with Univasc (View Usage). Patient had the following side effects: blood pressure inadequately controlled. Univasc dosage: 7.5mg, 1 In 1 D, Oral. During the same period patient was treated with CYCLOBENZAPRINE HCL (View Cyclobenzaprine Hcl Review and Cyclobenzaprine Hcl Label ).

5368534-3 | Arthralgia, Blood Pressure Inadequately Controlled, Fatigue, Flushing
Patient was taking Univasc (View Usage). After Univasc was administered, patient had the following side effects: arthralgia, blood pressure inadequately controlled, fatigue, flushing on Dec 18, 2006 from UNITED STATES Additional patient health information: Male patient , 66 years of age, weighting 205.0 lb, was diagnosed with hypertension and. Univasc dosage: 15mg, 1 In 1 D, Oral. During the same period patient was treated with IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), LOVASTATIN (View Lovastatin Review and Lovastatin Label ).

5368532-X | Abdominal Distension, Dysgeusia, Nausea
Adverse event was reported on Sep 01, 2006 by a Male patient taking Univasc (View Usage) (Dosage: See Image) was diagnosed with hypertension and. Location: UNITED STATES , 73 years of age, weighting 175.0 lb, Patient experienced the following unwanted or unexpected effects: abdominal distension, dysgeusia, nausea (What is nausea?).

5036014-0 | Loss Of Consciousness
on Apr 29, 2005 Male patient from UNITED STATES , 73 years of age, weighting 172.0 lb, was diagnosed with blood pressure (What is blood pressure?), constipation (What is constipation?) and was treated with Univasc (View Usage). Patient had the following side effects: loss of consciousness. Univasc dosage: Oral. During the same period patient was treated with METHYLCELLULOSE (Oral) (View Methylcellulose Review and Methylcellulose Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), GALANTAMINE HYDROBROMIDE (View Galantamine Hydrobromide Review and Galantamine Hydrobromide Label ).

4765404-6 | Asthenia, Fall, Metabolic Acidosis, Renal Failure Acute
on Sep 07, 2005 Male patient from UNITED STATES , 59 years of age, was treated with Univasc (View Usage). After Univasc was administered, patient had the following side effects: asthenia, fall (What is fall?), metabolic acidosis, renal failure acute. Univasc dosage: 15 Mg Daily. During the same period patient was treated with CELEBREX (100 Mg Daily) (View Celebrex Review and Celebrex Label ). Patient was hospitalized.

4758550-4 | Asthenia, Fall, Metabolic Acidosis, Renal Failure Acute
Patient was taking Univasc (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, fall (What is fall?), metabolic acidosis, renal failure acute on Aug 30, 2005 from UNITED STATES Additional patient health information: Male patient , 59 years of age, . Univasc dosage: 15 Mg Daily. During the same period patient was treated with CELEBREX (100 Mg Daily) (View Celebrex Review and Celebrex Label ). Patient was hospitalized.